Pharmaceutical

Tevogen Bio and Microsoft expand AI collaboration to PredicTcell tech

Tevogen Bio has expanded its partnership with Microsoft, aiming to further their collaboration centred on AI and advance PredicTcell.

Jan 28, 2025 - 06:00
Tevogen Bio and Microsoft expand AI collaboration to PredicTcell tech
Tevogen Bio has expanded its partnership with Microsoft, aiming to further their collaboration centred on AI and advance PredicTcell.
Read the original article

Tags:

Previous Article

The AI advantage in discovering new medicines 

Next Article

BIA report: UK biotech investment surged to £3.5bn in 2024

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Kezar and Everest enter lupus nephritis therapy development deal

Kezar and Everest enter lupus nephritis therapy develop...

Sep 21, 2023

FDA ARMAT status for Affimed and Artiva’s lymphoma combo therapy

FDA ARMAT status for Affimed and Artiva’s lymphoma comb...

Dec 7, 2024

Commercial drug manufacturing companies for the pharmaceutical industry

Commercial drug manufacturing companies for the pharmac...

Sep 22, 2024